Viking Therapeutics ( $VKTX) and the Push Toward $50: What Investors Should Know (Check any stock’s price target on Tickeron.) Investors are actively asking whether Viking Therapeutics (VKTX) can climb to $50, a round-number psychological target roughly 40% above recent trading levels. The strongest bull case rests on late-stage obesity candidate VK2735, with Phase 3 data and a potential blockbuster market opportunity driving analyst optimism. Wall Street maintains a consensus "Strong Buy" with an average price target near $95, well above the $50 milestone. $EDIT $KURA $BEAM $IMVT